Log In
Print this Print this

Zorvolex (Lower dose submicron diclofenac)

Also known as: IP 880

  Manage Alerts
Collapse Summary General Information
Company Iroko Pharmaceuticals LLC
DescriptionLower dose submicron formulation of the NSAID diclofenac using SoluMatrix fine particle technology
Molecular Target
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat mild to moderate acute pain in adults; Treat moderate to severe pain; Treat osteoarthritis (OA) pain; Treat osteoarthritis pain in adults; Treat post-surgical acute pain
Regulatory Designation U.S. - Undisclosed Review (Treat mild to moderate acute pain in adults)
PartnerAlgorithm S.A.L.;
Aspen Pharmacare Holdings Ltd.;
Calox de Costa Rica S.A.;
Endo International plc;
iCeutica Inc.;
Laboratorios Saval S.A.;
Landsteiner Scientific S.A. de C.V.;
PT Pratapa Nirmala-Fahrenheit

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today